These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
75 related items for PubMed ID: 9498636
1. Enhanced G protein activation in IDDM patients with diabetic nephropathy. Pietruck F, Spleiter S, Daul A, Philipp T, Derwahl M, Schatz H, Siffert W. Diabetologia; 1998 Jan; 41(1):94-100. PubMed ID: 9498636 [Abstract] [Full Text] [Related]
2. Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. Siffert W, Rosskopf D, Moritz A, Wieland T, Kaldenberg-Stasch S, Kettler N, Hartung K, Beckmann S, Jakobs KH. J Clin Invest; 1995 Aug; 96(2):759-66. PubMed ID: 7635969 [Abstract] [Full Text] [Related]
3. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study. Newman-Tancredi A, Cussac D, Audinot V, Pasteau V, Gavaudan S, Millan MJ. Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542 [Abstract] [Full Text] [Related]
4. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C. Yue TL, Stadel JM, Sarau HM, Friedman E, Gu JL, Powers DA, Gleason MM, Feuerstein G, Wang HY. Mol Pharmacol; 1992 Feb; 41(2):281-9. PubMed ID: 1311408 [Abstract] [Full Text] [Related]
5. Platelet-activating factor stimulates multiple signaling pathways in cultured rat mesangial cells. Kester M, Thomas CP, Wang J, Dunn MJ. J Cell Physiol; 1992 Nov; 153(2):244-55. PubMed ID: 1331121 [Abstract] [Full Text] [Related]
6. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands. Zhu J, Luo LY, Li JG, Chen C, Liu-Chen LY. J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330 [Abstract] [Full Text] [Related]
7. PAF receptors and G-proteins in human blood eosinophils and neutrophils. Agrawal DK, Ali N, Numao T. J Lipid Mediat; 1992 Aug; 5(2):101-4. PubMed ID: 1326343 [Abstract] [Full Text] [Related]
8. The class III antiarrhythmic drug amiodarone directly activates pertussis toxin-sensitive G proteins. Hagelüken A, Nürnberg B, Harhammer R, Grünbaum L, Schunack W, Seifert R. Mol Pharmacol; 1995 Feb; 47(2):234-40. PubMed ID: 7870030 [Abstract] [Full Text] [Related]
9. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients. Steinke JM, Mauer M, International Diabetic Nephropathy Study Group. Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710 [Abstract] [Full Text] [Related]
10. Premature cell ageing and evolution of diabetic nephropathy. Morocutti A, Earle KA, Rodemann HP, Viberti GC. Diabetologia; 1997 Feb; 40(2):244-6. PubMed ID: 9049488 [Abstract] [Full Text] [Related]
11. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus. González-Clemente JM, Mauricio D, Richart C, Broch M, Caixàs A, Megia A, Giménez-Palop O, Simón I, Martínez-Riquelme A, Giménez-Pérez G, Vendrell J. Clin Endocrinol (Oxf); 2005 Nov; 63(5):525-9. PubMed ID: 16268804 [Abstract] [Full Text] [Related]
12. Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils. Nakashima S, Suganuma A, Sato M, Tohmatsu T, Nozawa Y. J Immunol; 1989 Aug 15; 143(4):1295-302. PubMed ID: 2545786 [Abstract] [Full Text] [Related]
13. Hypertension in insulin-dependent diabetes. Norgaard K. Dan Med Bull; 1996 Feb 15; 43(1):21-38. PubMed ID: 8906979 [Abstract] [Full Text] [Related]
14. Change in the amount of body fat and IL-6 levels is related to altered insulin sensitivity in type 1 diabetes patients with or without diabetic nephropathy. Svensson MK, Eriksson JW. Horm Metab Res; 2011 Mar 15; 43(3):209-15. PubMed ID: 21321840 [Abstract] [Full Text] [Related]
15. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy. Möllsten A, Wessman M, Svensson M, Forsblom C, Parkkonen M, Brismar K, Groop PH, Dahlquist G. Ann Med; 2006 Mar 15; 38(7):522-8. PubMed ID: 17101543 [Abstract] [Full Text] [Related]
16. Involvement of a guanine-nucleotide-binding component in membrane IgM-stimulated phosphoinositide breakdown. Gold MR, Jakway JP, DeFranco AL. J Immunol; 1987 Dec 01; 139(11):3604-13. PubMed ID: 2824610 [Abstract] [Full Text] [Related]
17. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Barnas U, Schmidt A, Illievich A, Kiener HP, Rabensteiner D, Kaider A, Prager R, Abrahamian H, Irsigler K, Mayer G. Diabetologia; 1997 Mar 01; 40(3):327-31. PubMed ID: 9084972 [Abstract] [Full Text] [Related]
18. High prevalence of risk factors for cardiovascular disease in parents of IDDM patients with albuminuria. De Cosmo S, Bacci S, Piras GP, Cignarelli M, Placentino G, Margaglione M, Colaizzo D, Di Minno G, Giorgino R, Liuzzi A, Viberti GC. Diabetologia; 1997 Oct 01; 40(10):1191-6. PubMed ID: 9349601 [Abstract] [Full Text] [Related]
19. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Chico A, Pérez A, Córdoba A, Arcelús R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F. Diabetologia; 1998 Jun 01; 41(6):684-93. PubMed ID: 9662051 [Abstract] [Full Text] [Related]
20. Glomerular dysfunction in diabetic nephropathy. Zucchelli P, Zuccalà A, Sturani A. Postgrad Med J; 1988 Jun 01; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295 [Abstract] [Full Text] [Related] Page: [Next] [New Search]